Latest filing published 10 Jun 2025 for Context Therapeutics Inc., €22k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +129.0%Entry US$0.62 · Close at T+365 US$1.42
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jennifer Lynn Minai-Azary: trading record in brief
Jennifer Lynn Minai-Azary discloses dealings in Context Therapeutics Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 17 August 2022 and the latest from 6 June 2025.
Every open-market trade on record is a purchase: 3 purchases worth €66k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €22k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
On 10 June 2025 came the latest disclosure, an open-market purchase for €22k in Context Therapeutics Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jennifer Lynn Minai-Azary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,010 shares@ US$0.63733.6% of flowCommon StockSEC:0001842952-25-000060:0Canonical exit: 4 Sept 2025 (T+90)
- 25,000 shares@ US$0.7426.3% of flowCommon StockSEC:0001842952-22-000114:0Canonical exit: 16 Mar 2023 (T+90)
- 15,000 shares@ US$1.8040.1% of flowCommon StockSEC:0001842952-22-000079:0Canonical exit: 15 Nov 2022 (T+90)
3 of 3 declarations